← Back to Search

Refined Functional Communication Training for Behavioral Issues

N/A
Recruiting
Led By Wayne W Fisher, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 weeks.
Awards & highlights

Study Summary

This trial is testing whether using signals and gradually introducing new materials can help to prevent treatment relapse when transferring to a new environment or when treatment fidelity is poor.

Who is the study for?
This trial is for boys and girls aged 3 to 17 who exhibit destructive behavior, like aggression or self-harm, at least 10 times a day despite previous treatments. They must be on a stable medication regimen or drug-free and have consistent educational support with no expected changes during the study.Check my eligibility
What is being tested?
The study tests if adding treatment signals and gradually introducing everyday materials can prevent relapse when functional communication training (FCT) moves from clinic to home or is poorly implemented by teachers.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not applicable. However, there may be stress or frustration associated with adapting to new treatment methods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Destructive Behavior in Reinstatement Test
Rate of Destructive Behavior in Renewal Test
Rate of Destructive Behavior in Super-Resurgence Test

Trial Design

2Treatment groups
Experimental Treatment
Group I: Mult FCT/Trad FCTExperimental Treatment2 Interventions
Participants assigned to this condition will receive both traditional FCT (trad FCT) and FCT with multiple schedules (mult FCT) to evaluate the effects of mult FCT on renewal, super-resurgence, and reinstatement.
Group II: Mult FCT + Stimulus Fading/Trad FCTExperimental Treatment2 Interventions
Participants assigned to this condition will receive both traditional FCT (trad FCT) and FCT with multiple schedules and stimulus fading (mult FCT + stimulus fading) to evaluate the effects of mult FCT and gradual fading of contextual stimuli on renewal, super-resurgence, and reinstatement.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,208 Total Patients Enrolled
4 Trials studying Aggression
106 Patients Enrolled for Aggression
Wayne W Fisher, PhDPrincipal InvestigatorRutgers, The State University of New Jersey
1 Previous Clinical Trials
4 Total Patients Enrolled
1 Trials studying Aggression
4 Patients Enrolled for Aggression

Media Library

Mult FCT Clinical Trial Eligibility Overview. Trial Name: NCT04045600 — N/A
Aggression Research Study Groups: Mult FCT + Stimulus Fading/Trad FCT, Mult FCT/Trad FCT
Aggression Clinical Trial 2023: Mult FCT Highlights & Side Effects. Trial Name: NCT04045600 — N/A
Mult FCT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04045600 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I sign up for this medical investigation?

"In order to qualify for this clinical trial, participants should display aggression and must be between the ages of 3 and 17. At present, 24 individuals are being admitted into the study."

Answered by AI

How many participants can take part in this clinical trial?

"Affirmative. According to information available on clinicaltrial.gov, this medical study is actively looking for 24 patients from a single location. This trial was initially posted on May 3rd 2021 and the most recent update was made August 22nd 2022."

Answered by AI

Are there still any openings available for participants in this clinical trial?

"This investigation, which was first made available on May 3rd 2021 and most recently updated on August 22nd 2022, is presently recruiting participants as per the information stated on clinicaltrials.gov."

Answered by AI

Does the research include participants below the legal age of majority?

"The requirements for this trial state that the youngest participant must be at least 3 years old, whereas the oldest can not exceed 17."

Answered by AI
~9 spots leftby Dec 2025